SWITCHING FROM SUBCUTANEOUS TREPROSTINIL TO INHALED TREPROSTINIL IN PULMONARY ARTERIAL HYPERTENSION TREATMENT AND ECONOMIC IMPACT EVALUATION

Moya-Carmona, IPedrosa Ruiz, M.Estaun-Martinez, C.Ortiz, J.Mora-Santiago, M. R.2025-01-072025-01-072018-10-011098-3015https://hdl.handle.net/10668/26872enSWITCHING FROM SUBCUTANEOUS TREPROSTINIL TO INHALED TREPROSTINIL IN PULMONARY ARTERIAL HYPERTENSION TREATMENT AND ECONOMIC IMPACT EVALUATIONconference outputopen access10.1016/j.jval.2018.09.24031524-4733http://www.valueinhealthjournal.com/article/S109830151835705X/pdf459985604105